BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guarnera L, Ottone T, Fabiani E, Divona M, Savi A, Travaglini S, Falconi G, Panetta P, Rapanotti MC, Voso MT. Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis. Front Oncol 2022;12:871590. [PMID: 35494081 DOI: 10.3389/fonc.2022.871590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu G, Long J, Chen Y, Li L, Huan X, Long P. Acute promyelocytic leukemia with FIP1L1::RARA fusion gene: The clinical utility of transcriptome sequencing and bioinformatic analyses. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1049473] [Reference Citation Analysis]
2 Iyer SG, Elias L, Stanchina M, Watts J. The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1062524] [Reference Citation Analysis]
3 Chen L, Zhu H, Zhu Y, Jin W, Dong F, Li J, Hu J, Chen Q, Wang K, Li J. Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene. Front Oncol 2022;12:1013046. [DOI: 10.3389/fonc.2022.1013046] [Reference Citation Analysis]